AGA
Conditions
Interventions
None listed
Sponsors
Hiratyama Takashi
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: Patients who meet all of the following criteria will be eligible for the study: Male patients aged 18 years or older who have been diagnosed with androgenetic alopecia classified as Norwood type II to V Individuals with the capacity to provide informed consent Individuals who receive a thorough explanation of the treatment along with the informed consent document and voluntarily provide written consent Individuals deemed by the attending physician to require the treatment
Exclusion criteria
Exclusion criteria: Patients who meet any of the following conditions will be excluded from the study: Individuals who use narcotics or stimulants Individuals with severe heart disease or poorly controlled hypertension Individuals with a history of hypersensitivity to minoxidil or finasteride Individuals deemed inappropriate by the attending physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Photographic assessment of the scalp based on the Norwood classification Subjective evaluation using a self-administered questionnaire Interview and reporting of adverse effects (e.g., hypertrichosis, edema, headache, palpitations) Blood tests to monitor for adverse effects such as liver dysfunction | — |
Secondary
| Measure | Time frame |
|---|---|
| subjective symptoms, etc. | — |
Contacts
Public ContactTakashi Hirayama
OSAKA UMEDA SHINSHI CLINIC
Outcome results
None listed